BioTelemetry Stock News

The "Global Telemedicine Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

BioTelemetry Inc (NASDAQ:BEAT) – Stock analysts at Dougherty & Co issued their Q1 2020 earnings per share estimates for shares of BioTelemetry in a research report issued on Thursday, February 27th.

BioTelemetry Inc (NASDAQ:BEAT) was down 6.2% during trading on Thursday after Sidoti lowered their price target on the stock from $81.00 to $75.00. Sidoti currently has a buy rating on the stock. BioT

Analysts expect BioTelemetry Inc (NASDAQ:BEAT) to report sales of $110.35 million for the current quarter, Zacks reports. Three analysts have made estimates for BioTelemetry’s earnings, with the hig

BioTelemetry Inc (NASDAQ:BEAT) – Research analysts at Dougherty & Co dropped their FY2020 earnings per share estimates for BioTelemetry in a report issued on Monday, February 24th. Dougherty & Co an

...and steps on how to beat Mewtwo!

BioTelemetry, Inc. (NASDAQ:BEAT) Q4 2019 Earnings Conference Call February 26, 2020, 05:00 PM ET Company Participants Joseph Capper - President and CEO Heather

BEAT earnings call for the period ending December 31, 2019.

BioTelemetry (BEAT) delivered earnings and revenue surprises of 0.00% and 1.53%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

BioTelemetry (BEAT) delivered earnings and revenue surprises of 0.00% and 1.53%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

BioTelemetry Inc:

MALVERN, Pa. (AP) _ BioTelemetry Inc. (BEAT) on Wednesday reported fourth-quarter net income of $1.6 million. The Malvern, Pennsylvania-based company said it had net income of 4 cents per share. Earni